Currently more and more cancer centers are established in order to offer optimal multimodal therapy for patients with cancer. The primary aim of these centers is to combine therapy and research according to the already existing US models. The Nationales Centrum für Tumorerkrankungen(NCT) was recently founded in Heidelberg,a city particularly suited for such a national institution as it holds several large university hospitals of stellar reputation and the German Cancer Research Center (DKFZ). In this context the DKFZ has specifically built two new departments, one for translational oncology and another for preventive oncology. Additionally, the university hospital has founded a new department for medical oncology. The aim of the NCT is to treat all cancer patients within a multimodal concept. Moreover, as many patients as possible should be enrolled into studies. All clinical sections have access to the NCT study center. The study center supports the researches in all study-related aspects with the primary aim to incorporate study concepts into adequate protocols. Furthermore, a tissue bank has been established in order to enable access for researchers and clinicians to all tumor entities for research purposes. Practiced interdisciplinary working is the basic strategy for following the proposed goal. Only with considerable efforts of all involved parties a long-term improvement of oncological treatment modalities can be achieved.

This content is only available via PDF.
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.